News | Pfizer Pakistan

Connect With Us

Stay Informed,
Knowledge is power

Headlines, trainings, hot topics, and more.

Home

News

National Black Nurses Association RE:THINK Program

A conversation with Dr. Martha A. Dawson, National Black Nurses Association President

Learn More

Podcasts

Go behind the breakthroughs and explore the stories of the work we do at Pfizer, in conversations with the scientists and leaders who make it happen.

Listen Now

Science Will Win

Gene Therapy - Behind the Science

Listeners will hear from a diverse line-up of leading experts on the future-shaping science, challenging policy environment and the personal stories...

See all Episodes

The Antigen

Hear from leading experts about the past, present, and future of vaccines as well as the evolving conversation around COVID-19.

Listen Now

Diverse Perspectives The Antigen

Interviews with thought leaders who are pioneering change across a variety of industries

Listen Now

Hemcast

The recent COVID-19 pandemic has changed the clinical landscape, which has seen a rapid growth in the demand for telemedicine and digital health.

Listen Now

Menopause:
Unmuted

Menopause: Unmuted is a podcast series exploring first-hand experiences of this life stage.

Listen Now

Media Resources

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

09.30.2021

Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Health Literacy

COVID-19

Technology

Immunology

Autoimmune diseases

Focus areas

IBD

09.29.2021

Positive Top-line Results of Pfizer’s Phase 3 Study Exploring Coadministration of Prevnar 20™ With Seasonal Flu Vaccine in Older...

Health Literacy

COVID-19

Technology

Immunology

Autoimmune diseases

Focus areas

IBD

09.28.2021

Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate

Health Literacy

COVID-19

Technology

Immunology

Autoimmune diseases

Focus areas

IBD

View all releases

Product Pipeline

Our priority is researching and developing
medicines and vaccines that will benefit patients
around the world.

Download Complete Pipeline PDF

Clinical Trails

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to make things better.

Go to Pfizer Clinical Trials Site

Age

All

0-17 Years

18+ years

30+ years

50+ years

Placebo

All

Not Used

In Addition

Time Commitment

All

0-8 Weeks

2-6 Months

6+ Months

Trial Status

All

Not Yet Recruiting

Recruiting

Travel Distance

All

0-25 Miles

0-50 Miles

0-100 Miles

0-150 Miles

Careers

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to make things better.

Careers at Pfizer

People

Ramcess Jean-Louis is Ready to Build on...

We've implemented an unprecedented, comprehensive preparedness plan to control our site operations. Here's the latest.

Learn More

People

Meet Dacia Young, a Senior Scientist Within...

Meet Dacia Young, a Senior Scientist within the Vaccine Research and Development Group at Pfizer. Dacia has worked as...

Learn More

Investors

Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of medicines and vaccines.

Example

2020

Investment Report

2020

Investment Report

Careers News Report an Adverse Event

Our Purpose Our Science Our Manufacturing

Connect With Us Privacy Policy Terms of Use

Copyright © 2023 Pfizer Pakistan. All rights reserved. This information is intended for residents of Pakistan. The product information provided on the website relates to Products listed in Pakistan. These products may have different labeling in other markets. We are a subsidiary of Pfizer Inc., a pharmaceutical company committed to helping people improve their health by discovering and developing innovative medicines.
PP-UNP-PAK-0103, 2023-11

National Black Nurses Association RE:THINK Program​​​​​​​

Go behind the breakthroughs and explore the stories of the work we do at Pfizer, in conversations with the scientists and leaders who make it happen.

Gene Therapy - Behind the Science

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

Our priority is researching and developing medicines and vaccines that will benefit patients ​​​​​​​around the world.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to make things better.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to make things better.

Ramcess Jean-Louis is Ready to Build on...

Meet Dacia Young, a Senior Scientist Within...

Investment Report

National Black Nurses Association RE:THINK Program

Our priority is researching and developing
medicines and vaccines that will benefit patients
around the world.